Health Economic Modelling

Our Health Economic Modelling team supports evidence-based decision making throughout the product lifecycle, from early-stage assessments to Health Technology Assessment (HTA) ready submissions, supported by digital tools that strengthen value communication and payer engagement.

“The best analytical professional consultancy that I have worked with so far.”

Market Access Manager, Global Biopharma Company

Worker interprets Data

What We Offer

We design, build, and adapt models that communicate the value of your intervention with clarity, credibility, and technical rigour, drawing on extensive experience across key pharma markets, including the UK, Europe, US, Canada and Australia, as well as emerging markets.

A track record in user friendly, flexible, and easily adaptable health economic models.

Laptop showing dashboard

Strategic Understanding and Model Design

We work closely with clients to understand project objectives, target audiences, and evidence needs. By carefully reviewing available data and stakeholder input, we design fit-for-purpose models that align with both strategic priorities and payer expectations.

Advanced Analytics and Real-World Integration

Our team combines strong technical expertise with real-world insight. We are experienced in analysing individual patient data (IPD) and real-world evidence (RWE), conducting statistical analyses, and integrating these data into model frameworks. We engage with clinicians and external experts to validate model structures, key assumptions, and to fill data gaps, ensuring every model reflects both the best available evidence and clinical reality. We ensure model robustness through extensive sensitivity and scenario testing, exploring the impact of uncertainty and alternative assumptions on results.

Evidence Communication and Value Demonstration

In addition to technical excellence, we are experts in communicating model findings and translating results into clear, evidence-based value messages that support payer and stakeholder engagement.

Whether you need an early-stage model to inform internal decision making, an HTA-ready economic analysis, or an interactive tool for payer discussions, we deliver models that are not only technically robust but also practical, persuasive, and impactful.

Speak to Maverex

Demonstrate Your Value

Modelling Services From Maverex

Patient discusses their treatment
  • Early-stage modelling: Design and development of early economic models to support product development and evidence planning. These models explore the potential value of an intervention, identify evidence gaps, and inform trial design, endpoint selection, and pricing strategy. They help prioritise data collection and guide investment decisions before pivotal clinical evidence is available.

  • HTA-ready economic analyses: Design and build of de novo cost-effectiveness and budget impact models from the ground up in Excel or R, tailored to your product, indication, and target market. Our models are developed in line with HTA best practice, incorporating rigorous validation, sensitivity and scenario analyses, and comprehensive technical documentation suitable for submission.

  • Model adaptation: Localisation and adaptation of global or existing models to meet specific payer or HTA requirements.

  • Interactive payer tools: Development of web-based or tablet applications that bring models to life, helping field teams communicate value propositions clearly and effectively.

  • Model review and validation: Independent critical appraisal and validation of internal or external models to ensure methodological robustness, transparency, and compliance with HTA standards.

Our Services

From Real World Evidence and Environmental Impact Analysis, through to Market Access Materials and more. Maverex are perfectly positioned to support global Pharma and MedTech companies achieve success.

Learn more

Who We Are

A team of experienced professionals, focused on high-quality solutions and a commitment to environmental responsibility.

Meet The Team

Much More to Maverex

Experts in demonstrating product value, from clinical development to post-launch commercialisation.


  • Explore our latest peer-reviewed research publications, across nutrition, disease, the environment, market access and much more.

  • We take a personal approach to every project, and enjoy fantastic feedback from our clients as a result. Discover what they have to say about us on the Testimonials page.